Biotech · Private company · Palo Alto, CA, US
Greenstone Biosciences, Inc.
Track this companyFree. Adds Greenstone Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials1
- Mechanisms of Semaglutide Therapy in Heart Failure PatientsPHASE1_PHASE2 · UNKNOWN · started Jul 10, 2024ClinicalTrials.gov NCT06541509 · fetched Nov 12, 2026
NIH awards4
- Small Molecule Drug Discovery for Cardiac Fibrosis using AI/ML and iPSC-Derived OrganoidsFiscal year 2026 · $626KNIH RePORTER 1R61HL179715-01A1 · fetched Nov 12, 2026
- AI/ML and iPSC-Derived Organoids for Myotonic Dystrophy Drug DiscoveryFiscal year 2025 · $192.5KNIH RePORTER 5R21TR004938-02 · fetched Nov 12, 2026
- AI/ML and iPSC-Derived Organoids for Myotonic Dystrophy Drug DiscoveryFiscal year 2024 · $110KNIH RePORTER 1R21TR004938-01 · fetched Nov 12, 2026
- Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety TestingFiscal year 2024 · $1.4MNIH RePORTER 5R44HL170756-02 · fetched Nov 12, 2026